Mediantechn Cash Flow Conversion Efficiency

Latest as of December 2025: 0.301x

Mediantechn cash flow conversion efficiency. Based on the latest financial reports, Mediantechn (ALMDT) has a cash flow conversion efficiency ratio of 0.301x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-10.57 Million ≈ $-12.36 Million USD) by net assets (€-35.15 Million ≈ $-41.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Mediantechn (2013–2025)

Cash flow conversion efficiency of Mediantechn from 2013 to 2025. This chart illustrates how Mediantechn's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Mediantechn for real-time trading data and today's change.

Mediantechn Cash Flow Conversion Ratio Explained

Mediantechn cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Mediantechn Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mediantechn ranked by their cash flow conversion efficiency. Also see ALMDT stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Qudian Inc
F:1QU
N/A
Elektrotim SA
WAR:ELT
0.047x
ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft
F:HVB
-0.030x
Stellar V Capital Corp. Class A Ordinary Shares
NASDAQ:SVCC
-0.001x
US Gold Corp
NASDAQ:USAU
-0.078x
Kapston Services Limited
NSE:KAPSTON
0.016x
Mkango Resources Ltd
V:MKA
-0.145x
Yuan High-Tech Development Co Ltd
TWO:5474
-0.011x

Annual Cash Flow Conversion Efficiency for Mediantechn (2013–2025)

The table below shows the annual cash flow conversion efficiency of Mediantechn from 2013 to 2025. Review cash generation quality of Mediantechn to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €-35.15 Million
≈ $-41.10 Million
€-17.43 Million
≈ $-20.37 Million
0.496x -6.18%
2024-12-31 €-33.97 Million
≈ $-39.71 Million
€-17.95 Million
≈ $-20.98 Million
0.528x -73.12%
2023-12-31 €-10.29 Million
≈ $-12.03 Million
€-20.24 Million
≈ $-23.66 Million
1.966x -9.71%
2022-12-31 €-7.25 Million
≈ $-8.48 Million
€-15.79 Million
≈ $-18.46 Million
2.177x +206.22%
2021-12-31 €4.94 Million
≈ $5.77 Million
€-10.12 Million
≈ $-11.84 Million
-2.050x -526.68%
2020-12-31 €-11.36 Million
≈ $-13.28 Million
€-5.46 Million
≈ $-6.38 Million
0.480x +114.03%
2019-12-31 €1.28 Million
≈ $1.50 Million
€-4.39 Million
≈ $-5.13 Million
-3.424x -99.00%
2018-12-31 €9.09 Million
≈ $10.63 Million
€-15.64 Million
≈ $-18.29 Million
-1.721x -209.88%
2017-12-31 €24.94 Million
≈ $29.15 Million
€-13.85 Million
≈ $-16.19 Million
-0.555x -184.16%
2016-12-31 €38.74 Million
≈ $45.29 Million
€-7.57 Million
≈ $-8.85 Million
-0.195x -36.23%
2015-12-31 €26.24 Million
≈ $30.68 Million
€-3.76 Million
≈ $-4.40 Million
-0.143x +41.99%
2014-12-31 €13.78 Million
≈ $16.11 Million
€-3.41 Million
≈ $-3.98 Million
-0.247x --
2013-12-31 €0.00
≈ $0.00
€-4.42 Million
≈ $-5.16 Million
x --

About Mediantechn

PA:ALMDT France Medical Devices
Market Cap
$166.17 Million
€142.13 Million EUR
Market Cap Rank
#17067 Global
#247 in France
Share Price
€3.73
Change (1 day)
+5.67%
52-Week Range
€2.75 - €6.59
All Time High
€17.80
About

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnos… Read more